Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/29106
Type
ArticleCopyright
Open access
Sustainable Development Goals
05 Igualdade de gêneroCollections
- INI - Artigos de Periódicos [3488]
Metadata
Show full item record
THE COST-EFFECTIVENESS OF HIV PRE-EXPOSURE PROPHYLAXIS IN MEN WHO HAVE SEX WITH MEN AND TRANSGENDER WOMEN AT HIGH RISK OF HIV INFECTION IN BRAZIL
Author
Affilliation
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil
Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA./ Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil
Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA./ Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA
Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA./ Harvard University Center for AIDS Research, Harvard Medical School, Boston, MA, USA./ Department of Orthopedic Surgery, Brigham and Women's Hospital, Boston, MA, USA./ Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA
Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA./ Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil
Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA./ Harvard University Center for AIDS Research, Harvard Medical School, Boston, MA, USA./ Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA
Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA./ Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA. Harvard University Center for AIDS Research, Harvard Medical School, Boston, MA, USA./ Division of Infectious Disease, Massachusetts General Hospital, Boston, MA, USA./ Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA./ Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil
Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA./ Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA. Harvard University Center for AIDS Research, Harvard Medical School, Boston, MA, USA./ Division of Infectious Disease, Massachusetts General Hospital, Boston, MA, USA./ Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, USA
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil
Yale School of Public Health, New Haven, CT, USA
Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA./ Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil
Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA./ Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA
Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA./ Harvard University Center for AIDS Research, Harvard Medical School, Boston, MA, USA./ Department of Orthopedic Surgery, Brigham and Women's Hospital, Boston, MA, USA./ Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA
Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA./ Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil
Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA./ Harvard University Center for AIDS Research, Harvard Medical School, Boston, MA, USA./ Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA
Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA./ Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA. Harvard University Center for AIDS Research, Harvard Medical School, Boston, MA, USA./ Division of Infectious Disease, Massachusetts General Hospital, Boston, MA, USA./ Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA./ Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil
Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA./ Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA. Harvard University Center for AIDS Research, Harvard Medical School, Boston, MA, USA./ Division of Infectious Disease, Massachusetts General Hospital, Boston, MA, USA./ Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, USA
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil
Yale School of Public Health, New Haven, CT, USA
Abstract
Men who have sex with men (MSM) and transgender women (TGW) in Brazil experience high rates of HIV infection. We examined the clinical and economic outcomes of implementing a pre-exposure prophylaxis (PrEP) programme in these populations.
Share